Caplin Point Laboratories Limited
NSE: CAPLIPOINTINE475E01026·HealthcareSmallcap 250·www.caplinpoint.net ↗·Mcap ₹21,217 Cr·Listed 2014
₹2,835.10▼ ₹32.30  (−1.13%)
52W: ₹1,500 – ₹2,990 · Vol: 1.8L shares · Close 25 Sept
Set Alert
Overlay:
daily candles · adjustedloading full history…Charts by TradingView
Ask the chart: “Has this stock recovered from similar drawdowns before?”
Annual report FY26 — 17.88 MB · Shareholding pattern — Jun 2026 · All filings
AI equity note (bull/bear, numbers, sources) — coming soon
Management guidance consistency — coming soon

Latest filings

NSE announcements · newest first
No filings on record for CAPLIPOINT yet.
P/E (TTM)
31.8×
EPS ₹89.22
P / Book
6.01×
BVPS ₹472
ROE
20.2%
FY26, avg equity
Net margin
29.7%
FY26
Revenue YoY
+19.6%
Q1 FY27
Net profit YoY
+18.8%
Q1 FY27
Debt / equity
0.00×
₹1 Cr debt
Div. yield
0.28%
₹8.00 in 12 months
From NSE filings (consolidated) and the last close.
Shareholding Pattern Jun 2026
Promoters
70.6%—
FIIs
5.8%▼ 0.40
DIIs
2.5%▲ 0.35
Retail
14.6%▲ 0.16
Others
6.6%▼ 0.11
Promoter pledge: none reported
Peer Comparison
Peer comparison is unavailable right now.
Forensic Flags
Forensic checks are unavailable right now.